Analyst Research

Report Title Price
Provider: Ford Investor Services, Inc.
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Plunkett Research, Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elite Pharmaceuticals Inc Announces Change In Executive Leadership

Tuesday, 21 May 2013 11:49am EDT 

Elite Pharmaceuticals Inc announced that Chris Dick will step down as President and Chief Operating Officer (COO) and as a member of the Board of Directors, effective May 24, 2013. Mr. Dick will remain as a consultant with Elite to ensure a smooth transition while the Board conducts a search for a permanent replacement. 

Company Quote

0.0028 +0.82%
17 Apr 2014